REQUEST A DEMO
Total
USD $0.00
Search more companies

Tci Gene Inc. (大江基因医学股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tci Gene Inc. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Tci Gene Inc. (大江基因医学股份有限公司) is an enterprise located in Taiwan, China, with the main office in Taipei City. The company operates in the Pharmaceutical and Medicine Manufacturing sector. Tci Gene Inc. (大江基因医学股份有限公司) was incorporated on July 13, 2011. 53 (2023) employees currently work for Tci Gene Inc. (大江基因医学股份有限公司). From the latest financial highlights, Tci Gene Inc. (大江基因医学股份有限公司) reported a net sales revenue drop of 13.86% in Q2C2025. Its total assets decreased by 9.45% over the same period. The net profit margin of Tci Gene Inc. (大江基因医学股份有限公司) decreased by 13.59% in 2025.

Headquarters
10F., No. 185-1, Gangqian Rd, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Tci Gene Inc. (大江基因医学股份有限公司) report to view the information.

Website: http://www.genext.me

Basic Information
Total Employees:
Purchase the Tci Gene Inc. (大江基因医学股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Tci Gene Inc. (大江基因医学股份有限公司) report to view the information.
Financial Auditors:
Purchase the Tci Gene Inc. (大江基因医学股份有限公司) report to view the information.
Incorporation Date:
July 13, 2011
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
42.23%
Purchase this report to view the information.
17.84%
Purchase this report to view the information.
13.75%
Purchase this report to view the information.
5.59%
Purchase this report to view the information.
3.17%
Subsidiaries
Glux Hk Limited (Hong Kong SAR, China)
100%
大江生活股份有限公司
79.31%
TCI Co.,Ltd
4.24%
Company Performance
Financial values in the chart are available after Tci Gene Inc. (大江基因医学股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-13.86%
Total Operating Revenue
-14.8%
Operating Profit
-84.93%
EBITDA
-18.79%
Net Profit/Loss for the Period
-97.27%
Total Assets
-9.45%
Total Equity
-12.8%
Operating Profit Margin
-15.35%
Net Profit Margin
-13.59%
Return on Equity (ROE)
-2.1%
Debt / Equity
1070%
Quick Ratio
-1219.34%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?